Lead time associated with screening for prostate cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Lead time associated with screening for prostate cancer

Published:2003-10-07 Issue:1 Volume:108 Page:122-129
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Törnblom Magnus,Eriksson Henry,Franzén Stefan,Gustafsson Ove,Lilja Hans,Norming Ulf,Hugosson Jonas

Funder

Swedish Cancer Society

Thure and Brita Grafström Foundation

Swedish Research Council, Medicine, 7903

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference29 articles.

1. Annual report to the nation on the status of cancer (1973 through 1998), featuring cancers with recent increasing trends;Howe;J Natl Cancer Inst,2001

2. Trends in mortality rates in patients with prostate cancer during the era of prostate specific antigen screening;Merrill;J Urol,2000

3. Prostate cancer mortality after introduction of prostate-specific antigen mass screening in the Federal State of Tyrol, Austria;Bartsch;Urology,2001

4. Screening decreases prostate cancer death: first analysis of the 1988 Quebec prospective randomized controlled trial;Labrie;Prostate,1999

5. Should we start population screening for prostate cancer? Randomised trials are still needed;Auvinen;Int J Cancer,2002

Cited by 74 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Considering the role of radical prostatectomy in 21st century prostate cancer care;Nature Reviews Urology;2020-02-21

2. Prostate cancer incidence across stage, NCCN risk groups, and age before and after USPSTF Grade D recommendations against prostate‐specific antigen screening in 2012;Cancer;2019-12-03

3. Subtypes of minimal residual disease, association with Gleason score, risk and time to biochemical failure in pT2 prostate cancer treated with radical prostatectomy;ecancermedicalscience;2019-06-06

4. Long-Term Clinical Outcomes of Radical Prostatectomy versus Watchful Waiting in Localized Prostate Cancer Patients: A Systematic Review and Meta-Analysis;Iranian Journal of Public Health;2019-05-22

5. “Reverse Stage Migration”: What Can Population-based Data Tell Us About Trends in Prostate Cancer Presentation?;European Urology Oncology;2018-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3